GB201006818D0 - Drug delivery - Google Patents

Drug delivery

Info

Publication number
GB201006818D0
GB201006818D0 GBGB1006818.7A GB201006818A GB201006818D0 GB 201006818 D0 GB201006818 D0 GB 201006818D0 GB 201006818 A GB201006818 A GB 201006818A GB 201006818 D0 GB201006818 D0 GB 201006818D0
Authority
GB
United Kingdom
Prior art keywords
drug delivery
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1006818.7A
Other versions
GB2469754B (en
GB2469754A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LondonPharma Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2009/050416 external-priority patent/WO2010122276A1/en
Application filed by Individual filed Critical Individual
Publication of GB201006818D0 publication Critical patent/GB201006818D0/en
Publication of GB2469754A publication Critical patent/GB2469754A/en
Application granted granted Critical
Publication of GB2469754B publication Critical patent/GB2469754B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
GB1006818.7A 2009-04-23 2010-04-23 Composition for use in the sublingual delivery of medicaments to humans Expired - Fee Related GB2469754B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0906977A GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
PCT/GB2009/050416 WO2010122276A1 (en) 2009-04-23 2009-04-23 Drug delivery

Publications (3)

Publication Number Publication Date
GB201006818D0 true GB201006818D0 (en) 2010-06-09
GB2469754A GB2469754A (en) 2010-10-27
GB2469754B GB2469754B (en) 2012-07-18

Family

ID=40774840

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0906977A Withdrawn GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
GB1006818.7A Expired - Fee Related GB2469754B (en) 2009-04-23 2010-04-23 Composition for use in the sublingual delivery of medicaments to humans

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB0906977A Withdrawn GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery

Country Status (1)

Country Link
GB (2) GB2469792A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2481619B (en) * 2010-06-30 2012-06-20 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
GB201414919D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
WO2018169497A1 (en) * 2017-03-17 2018-09-20 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Spray formulation comprising cholecalciferol (vitamin d3) with improved stability
US20220312826A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Liquid mixtures of triglyceride and liquid nicotine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4292993A (en) * 1992-04-27 1993-11-29 Vyrex Corporation Improved delivery formulation for lipophilic drugs
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
AU737983B2 (en) * 1996-12-12 2001-09-06 Pharmacia & Upjohn Company An oil composition of dihydropolyprenols
SE9703458D0 (en) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
IT1302682B1 (en) * 1998-10-16 2000-09-29 Formenti Farmaceutici Spa ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENORPHINE
US6617356B2 (en) * 2000-01-03 2003-09-09 Naturally Scientific Inc Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements
GB2380129B (en) * 2001-02-14 2004-08-11 Gw Pharma Ltd Pharmaceutical formulations
WO2005123090A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
GB0513984D0 (en) * 2005-07-07 2005-08-17 Teva Pharma Dosage form
RU2432950C2 (en) * 2006-01-25 2011-11-10 Инсис Терапьютикс Инк. Sublingual fentanyl-based spray
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
US20070287755A1 (en) * 2006-06-12 2007-12-13 Rosario Ammirante Orally administered compound for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin dificiency
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition

Also Published As

Publication number Publication date
GB2469754B (en) 2012-07-18
GB2469792A (en) 2010-11-03
GB0906977D0 (en) 2009-06-03
GB2469754A (en) 2010-10-27

Similar Documents

Publication Publication Date Title
HK1166731A1 (en) Drug delivery device
EP2401012A4 (en) Drug delivery system
PT2398500T (en) Glutathione-based drug delivery system
IL215608A0 (en) Drug delivery composition
HK1164759A1 (en) Medicament delivery devices
HK1164758A1 (en) Medicament delivery devices
HK1164176A1 (en) Medicament delivery devices
IL215219A0 (en) Drug delivery device
IL218839A0 (en) Drug delivery device
HK1166728A1 (en) Drug delivery device
EP2485786A4 (en) Medicament delivery device
EP2493529A4 (en) Medicament delivery device
EP2421587A4 (en) Medicament delivery device
GB201217611D0 (en) Immediate/delayed drug delivery
EP2482874A4 (en) Medicament delivery device
EP2391419A4 (en) Posterior segment drug delivery
ZA201106668B (en) Zoo-technical drug delivery device
EP2481399A4 (en) Sustained drug delivery system
EP2506909A4 (en) Drug delivery device
EP2496292A4 (en) Medicament delivery device
IL217416A0 (en) Drug delivery delivery device
PL2493459T3 (en) Ocular drug delivery devices
PL2437736T3 (en) Drug delivery systems
GB201006818D0 (en) Drug delivery
PT2485786T (en) Medicament delivery device

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: LONDONPHARMA LIMITED

Free format text: FORMER OWNER: CALVIN JOHN ROSS

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20210423

S28 Restoration of ceased patents (sect. 28/pat. act 1977)

Free format text: APPLICATION FILED

S28 Restoration of ceased patents (sect. 28/pat. act 1977)

Free format text: RESTORATION ALLOWED

Effective date: 20220511

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20230423